{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:07:25Z","timestamp":1793398045677,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DA032674"],"award-info":[{"award-number":["DA032674"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004866","name":"New York State Office of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004866","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.drugalcdep.2016.03.028","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T21:50:07Z","timestamp":1462398607000},"page":"14-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":182,"special_numbering":"C","title":["Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City"],"prefix":"10.1016","volume":"164","author":[{"given":"Helena","family":"Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Wanderling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danae","family":"DiRocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0005","first-page":"1","article-title":"Summary health statistics for the U.S. population: national health interview survey 2009","volume":"10","author":"Adams","year":"2009","journal-title":"Vital Health Stat."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0010","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1590\/S1415-790X2010000400001","article-title":"Spatial distribution of mortality by homicide and social inequalities according to race\/skin color in an intra-urban Brazilian space","volume":"13","author":"Araujo","year":"2010","journal-title":"Rev. Bras. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0015","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11606-008-0881-9","article-title":"Integrating buprenorphine treatment into office-based practice: a qualitative study","volume":"24","author":"Barry","year":"2009","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.diabet.2010.07.004","article-title":"Prevalence of treated diabetes: geographical variations at the small-area level and their association with area-level characteristics. A multilevel analysis in Southeastern France","volume":"37","author":"Bocquier","year":"2011","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0025","author":"Centers for Disease Control (CDC)","year":"2015","journal-title":"CDC Fact Sheet: HIV among African Americans"},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0030","author":"Centers for Disease Control (CDC)","year":"2015","journal-title":"CDC Fact Sheet: HIV among Latinos."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0035","author":"Centers for Disease Control (CDC)","year":"2015","journal-title":"Health Disparities in HIV\/AIDS, Viral Hepatitis, STDs, and TB."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0040","unstructured":"Centers for Disease Control and Prevention (CDC), 2012. Estimated HIV incidence in the United States, 2007\u20132010. HIV Surveillance Supplemental Report 17."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0045","author":"Centers for Disease Control and Prevention (CDC)","year":"2014","journal-title":"Prescription Drug Overdose in the United States: Fact Sheet."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0050","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1186\/1471-2458-10-664","article-title":"Ecological analysis of health care utilization for China\u2019s rural population: association with a rural county\u2019s socioeconomic characteristics","volume":"10","author":"Chau","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0055","first-page":"336","article-title":"Attending physicians\u2019 and residents\u2019 attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital","volume":"38","author":"Cunningham","year":"2006","journal-title":"Fam. Med."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0060","first-page":"500","article-title":"Buprenorphine treatment in an urban community health center: what to expect","volume":"40","author":"Cunningham","year":"2008","journal-title":"Fam. Med."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0065","doi-asserted-by":"crossref","first-page":"c5367","DOI":"10.1136\/bmj.c5367","article-title":"Understanding the effect of ethnic density on mental health: multi-level investigation of survey data from England","volume":"341","author":"Das-Munshi","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1747-597X-3-17","article-title":"State policy influence on the early diffusion of buprenorphine in community treatment programs","volume":"3","author":"Ducharme","year":"2008","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0075","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s11606-010-1377-y","article-title":"The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand\/improve buprenorphine treatment","volume":"25","author":"Egan","year":"2010","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0080","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1111\/j.1360-0443.2005.01271.x","article-title":"Harm reduction interventions, behaviours and associated health outcomes in France, 1996\u20132003","volume":"100","author":"Emmanuelli","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0085","first-page":"340","article-title":"2000. An overview of heroin trends in New York City: past, present and future","volume":"67","author":"Frank","year":"2000","journal-title":"Mt. Sinai J. Med."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0090","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1353\/dem.0.0017","article-title":"Technological innovation and inequality in health","volume":"45","author":"Glied","year":"2008","journal-title":"Demography"},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0095","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/0022427891028002005","article-title":"Social area influences on delinquency: a multilevel analysis","volume":"28","author":"Gottfredson","year":"1991","journal-title":"J. Res. Crime Delinq."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0100","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1476-072X-5-58","article-title":"On the use of ZIP codes and ZIP code tabulation areas (ZCTAs) for the spatial analysis of epidemiological data","volume":"5","author":"Grubesic","year":"2006","journal-title":"Int. J. Health Geogr. Dec."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1108\/S1057-6290(2012)0000014008","article-title":"Two tiers of biomedicalization: buprenorphine: methadone and the biopolitics of addiction stigma and race","volume":"14","author":"Hansen","year":"2012","journal-title":"Adv. Med. Soc."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0110","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11414-013-9341-3","article-title":"Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City","volume":"40","author":"Hansen","year":"2013","journal-title":"J. Behav. Health Serv. Res."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/02791072.2011.587704","article-title":"Integrating buprenorphine treatment into a public healthcare system: the San Francisco Department of Public Health\u2019s office-based buprenorphine pilot program","volume":"43","author":"Hersh","year":"2011","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0120","article-title":"Theory-based social area analysis: an approach considering the conditions of a post-industrial society","author":"Heye","year":"2005","journal-title":"14th European Colloquium on Theoretical and Quantitative Geography, 2005"},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0125","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1370\/afm.1595","article-title":"Barriers to primary care physicians prescribing buprenorphine","volume":"12","author":"Hutchinson","year":"2014","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/0974-2700.50878","article-title":"Etiological characterization of acute poisonings in the emergency department","volume":"2","author":"Khlifi","year":"2009","journal-title":"J. Emerg. Trauma Shock"},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0135","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/08897077.2011.620475","article-title":"Buprenorphine-naloxone maintenance following release from jail","volume":"33","author":"Lee","year":"2012","journal-title":"Subst. Abuse"},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0140","first-page":"1","article-title":"Surveillance of Health Status in Minority Communities\u2014racial and Ethnic Approaches to Community Health Across the U.S. (REACH U.S.) Risk Factor Survey United States 2009","volume":"60","author":"Liao","year":"2011","journal-title":"MMWR Surveill. Summ."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0145","doi-asserted-by":"crossref","DOI":"10.2307\/2626958","article-title":"Social conditions as fundamental causes of disease","author":"Link","year":"1995","journal-title":"J. Health Soc. Behav."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0150","series-title":"Global Pharmaceuticals","article-title":"Addiction markets: high dose buprenorphine in France","author":"Lovell","year":"2006"},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0155","first-page":"161","article-title":"Drug-induced deaths\u2212United States 1999\u20132010","volume":"62","author":"Mack","year":"2013","journal-title":"MMWR Suppl."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0160","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.08.006","article-title":"Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial","volume":"99","author":"Magura","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0165","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0170","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/1471-2458-12-443","article-title":"Estimating the prevalence of illicit opioid use in New York City using multiple data sources","volume":"12","author":"McNeely","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0175","doi-asserted-by":"crossref","DOI":"10.1177\/1363461516660884","article-title":"in press Shifting blame: buprenorphine prescribers, addiction treatment, and prescription monitoring in middle-class America","author":"Mendoza","year":"2016","journal-title":"Transcult. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0180","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.drugalcdep.2011.09.009","article-title":"African American patients seeking treatment in the public sector: characteristics of buprenorphine vs methadone patients","volume":"122","author":"Mitchell","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0185","series-title":"Report I: Availability Without Accessibility? State Medicaid Coverage And Authorization Requirements For Opioid Dependence Medications The Avisa Group","author":"Rinaldo","year":"2013"},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0190","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.jsat.2009.12.008","article-title":"A longitudinal study of organizational formation innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network","volume":"1","author":"Roman","year":"2010","journal-title":"J. Subst. Abuse Treat. 38 Suppl."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0195","series-title":"SAS\/STAT\u00ae 9.2 User\u2019s Guide","author":"S.A.S. Institute, Inc","year":"2008"},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0200","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2105\/AJPH.2012.301049","article-title":"Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995\u20132009","volume":"103","author":"Schwartz","year":"2013","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0205","first-page":"199","article-title":"Social area analysis in community medicine","volume":"31","author":"Scott-Samuel","year":"1977","journal-title":"Br. J. Prev. Soc. Med."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0210","series-title":"Social Area Analysis: Theory, Illustrative Application And Computational Procedures","author":"Shevky","year":"1995"},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0215","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.drugpo.2013.10.015","article-title":"Unintentional opioid overdose deaths in New York City, 2005\u20132010: a place-based approach to reduce risk","volume":"25","author":"Siegler","year":"2014","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0220","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1057\/hsq.2010.20","article-title":"Inequalities in disability-free life expectancy by area deprivation: England 2001\u201304 and 2005\u201308","volume":"48","author":"Smith","year":"2010","journal-title":"Health Stat. Q."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0225","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/10550887.2012.694603","article-title":"Opioid maintenance treatment as harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine\/naloxone in marginalized populations","volume":"31","author":"Stancliff","year":"2012","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0230","series-title":"SAMHSA\/CSAT Evaluation Of The Buprenorphine Waiver Program: Expanding Treatment Of Opioid Dependence: Initial Physician And Patient Experiences With The Adoption Of Buprenorphine","author":"Stanton","year":"2006"},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0235","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/1468-0009.12137","article-title":"Where is buprenorphine dispensed to treat opioid use disorders? The role of private offices, opioid treatment programs, and substance abuse treatment facilities in urban and rural counties","volume":"93","author":"Stein","year":"2015","journal-title":"Milbank Q."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0240","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jsat.2014.07.010","article-title":"Supply of buprenorphine waivered physicians: the influence of state policies","volume":"48","author":"Stein","year":"2015","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0245","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1158\/1055-9965.EPI-09-0305","article-title":"Medical advances and racial\/ethnic disparities in cancer survival","volume":"18","author":"Tehranifar","year":"2009","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0250","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1176\/ps.2008.59.8.909","article-title":"Use of buprenorphine for addiction treatment: perspectives of addiction specialists and general psychiatrists","volume":"59","author":"Thomas","year":"2008","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0255","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/archinte.165.15.1769","article-title":"Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence","volume":"165","author":"Turner","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0260","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5055\/jom.2009.0007","article-title":"Buprenorphine: a review","volume":"5","author":"Wakhlu","year":"2009","journal-title":"J. Opioid Manag."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0265","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s11606-008-0686-x","article-title":"Office-based management of opioid dependence with buprenorphine: clinical practices and barriers","volume":"23","author":"Walley","year":"2008","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0270","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jsat.2006.11.003","article-title":"Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services","volume":"33","author":"Whitley","year":"2007","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2016.03.028_bib0275","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2105\/AJPH.2007.131714","article-title":"The promotion and marketing of oxycontin: commercial triumph, public health tragedy","volume":"99","author":"Zee","year":"2009","journal-title":"Am. J. Public Health"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871616300746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871616300746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T22:07:13Z","timestamp":1655676433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871616300746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":55,"alternative-id":["S0376871616300746"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.03.028","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}